StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note released on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
The stock has a market cap of $833,000.00, a PE ratio of -0.01 and a beta of -0.90. Athersys has a one year low of $0.01 and a one year high of $1.99.
Athersys Company Profile
Further Reading
- Five stocks we like better than Athersys
- The 3 Best Fintech Stocks to Buy Now
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Investing In Automotive Stocks
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.